This Article Full Text Full Text (PDF) All Versions of this Article: 40/6/2182    most recent STROKEAHA.108.523720v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Friedman, B. Articles by Lyden, P. D. Search for Related Content PubMed PubMed Citation Articles by Friedman, B. Articles by Lyden, P. D. Related Collections Animal models of human disease Pathology of Stroke Other Vascular biology

(Stroke. 2009;40:2182.)
© 2009 American Heart Association, Inc.

Original Contributions

Acute Vascular Disruption and Aquaporin 4 Loss After Stroke

Beth Friedman, PhD; Christian Schachtrup, PhD; Philbert S. Tsai, PhD; Andy Y. Shih, PhD; Katerina Akassoglou, PhD; David Kleinfeld, PhD Patrick D. Lyden, MD

From the Department of Neurosciences, Department of Pharmacology, UCSD School of Medicine, the Department of Physics, UCSD, and Veterans Administration Medical Center, San Diego, Calif.

Correspondence to Patrick D. Lyden, MD, FAAN, FAHA, Stroke Center, 200 West Arbor Drive, San Diego, CA 92103-8466. E-mail plyden{at}ucsd.edu

Background and Purpose— Ischemic protection has been demonstrated by a decrease in stroke-infarct size in transgenic mice with deficient Aquaporin 4 (AQP4) expression. However, it is not known whether AQP4 is rapidly reduced during acute stroke in animals with normal AQP4 phenotype, which may provide a potential self-protective mechanism.

Methods— Adult male rats underwent transient occlusion of the middle cerebral artery (tMCAo) for 1 to 8 hours followed by reperfusion for 30 minutes. Protein and mRNA expression of AQP4 and glial fibrillary acidic protein (GFAP) were determined by Western blot and rtPCR. Fluorescence quantitation was obtained with laser scanning cytometery (LSC) for Cy5-tagged immunoreactivity along with fluorescein signals from pathological uptake of plasma-borne high-molecular-weight fluorescein-dextran. Cell death was assessed with in vivo Propidium Iodide (PI) nucleus labeling.

Results— In the ischemic hemisphere in tissue sections, patches of fluorescein-dextran uptake were overlapped with sites of focal loss of AQP4 immunoreactivity after tMCAo of 1 to 8 hours duration. However, the average levels of AQP4 protein and mRNA, determined in homogenates of whole striatum, were not significantly reduced after 8 hours of tMCAo. Tissue section cytometry (LSC) of immunoreactivity in scan areas with high densities of fluorescein-dextran uptake demonstrated reductions in AQP4, but not in IgG or GFAP, after tMCAo of 2 hours or longer. Scan areas with low densities of fluorescein-dextran did not lose AQP4. There was sparse astrocyte cell death as only 1.7±0.85% (mean, SD) of DAPI labeled cells were PI- and GFAP-labeled after 8 hours of tMCAo.

Conclusions— During acute tMCAo, a rapid loss of AQP4 immunoreactivity from viable astrocytes can occur. However, AQP4 loss is spatially selective and occurs primarily in regions of vascular damage.

Key Words: Aquaporin 4 • blood brain barrier breakdown • stroke

This article has been cited by other articles:

				B. Chen, B. Friedman, Q. Cheng, P. Tsai, E. Schim, D. Kleinfeld, and P. D. Lyden Severe Blood-Brain Barrier Disruption and Surrounding Tissue Injury Stroke, December 1, 2009; 40(12): e666 - e674. [Abstract] [Full Text] [PDF]